34573-36-9

Basic information

• Product Name: Glycine, N-[(1,1-dimethylethoxy)carbonyl]-, chloromethyl ester
• Synonyms: tert-Butoxycarbonylamino-acetic acid chloromethyl ester;N-tert.butoxycarbonyl-glycine chloromethyl ester;N-Boc-glycine chloromethylester;N-tert.-Butoxycarbonyl-glycin-chlormethylester;N-tert-butoxycarbonyl-glycine chloromethyl ester
• CAS NO: 34573-36-9
• Molecular Formula: C8H14ClNO4
• Molecular Weight: 223.656
• Mol File: 34573-36-9.mol
• Article Data: 13

Chemical Properties

• Boiling Point: 302.4±22.0 °C(Predicted)
• Density: 1.190±0.06 g/cm3(Predicted)
• CAS DataBase Reference: Glycine, N-[(1,1-dimethylethoxy)carbonyl]-, chloromethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Glycine, N-[(1,1-dimethylethoxy)carbonyl]-, chloromethyl ester(34573-36-9)
• EPA Substance Registry System: Glycine, N-[(1,1-dimethylethoxy)carbonyl]-, chloromethyl ester(34573-36-9)

Safety Data

• Hazardous Substances Data: 34573-36-9(Hazardous Substances Data)

Upstream product

• 4530-20-5 BOC-glycine 
• 593-71-5 Chloroiodomethane 
• 74-97-5 chlorobromomethane 
• 42538-64-7 Boc-glycine cesium salt 
• 49715-04-0 chlorosulfuric acid chloromethyl ester 

Downstream Products

• 150082-92-1 tert-Butoxycarbonylamino-acetic acid 3-[(2R,4S,5R)-4-(4-chloro-benzyloxy)-5-hydroxymethyl-tetrahydro-furan-2-yl]-5-fluoro-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-ylmethyl ester 
• 913841-89-1 tert-butoxycarbonylamino-acetic acid {[4-(3,3-dimethyl-butyrylamino)-benzoyl]-thiazol-2-yl-amino}-methyl ester 
• 150083-10-6 tert-Butoxycarbonylamino-acetic acid 3-[(2R,4S,5R)-4-(4-chloro-benzyloxy)-5-(2-dimethylamino-acetoxymethyl)-tetrahydro-furan-2-yl]-5-fluoro-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-ylmethyl ester 
• 752181-34-3 tert-Butoxycarbonylamino-acetic acid 3-[(2R,4S,5R)-4-(4-chloro-benzyloxy)-5-(2-methylamino-acetoxymethyl)-tetrahydro-furan-2-yl]-5-fluoro-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-ylmethyl ester 
• 765878-52-2 tert-Butoxycarbonylamino-acetic acid 3-[(2R,4S,5R)-5-(2-amino-acetoxymethyl)-4-(4-chloro-benzyloxy)-tetrahydro-furan-2-yl]-5-fluoro-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-ylmethyl ester 
• 70579-75-8 (6R)-7t-((R)-2-hydroxy-2-phenyl-acetylamino)-3-(1-methyl-1H-tetrazol-5-ylsulfanylmethyl)-8-oxo-(6rH)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid N-tert-butoxycarbonyl-glycyloxymethyl ester 

Relevant articles and documents

PRODRUGS OF MYELOPEROXIDASE INHIBITORS

Disclosed are prodrugs of myeloperoxidase (MPO) inhibitors, methods of treating MPO related disorders, e.g., multiple system atrophy, amyotrophic lateral sclerosis, and Huntingtons disease, and methods of neuroprotection, which include administering to a

TERTIARY AMINE COMPOUND OR IMINE COMPOUND-POLYMER CONJUGATE AND PRODUCTION METHOD THEREFOR

Provided is a compound obtained by conjugating a tertiary amine compound or imine compound, which is useful as a drug, with a polymer, in which a structure D+ having a quaternary ammonium salt or iminium salt formed from a tertiary amine compound or imine compound D and a polymer residue Poly having a carboxy group are bonded to each other via a structure —C(R1)(R2)OC(O)ANHC(═O)—.

POMALIDOMIDE DERIVATIVES AND THE PREPARING METHOD THEREOF

The invention relates to pomalidomide derivatives and their stereoisomers or pharmaceutically acceptable salts, and their use in preparing medicaments for treating cancers.